Clinical and immunological manifestations of patients with primary SS (SS) and HGV infection compared with patients without HGV infection
| SS with HGV infection (n=4) (%) | SS without HGV infection (n=96) (%) | p Value | |
|---|---|---|---|
| Dry mouth | 3 (75) | 95 (99) | NS |
| Dry eyes | 3 (75) | 92 (96) | NS |
| Parotidomegaly | 3 (75) | 34 (35) | NS |
| Esplenomegaly | 1 (25) | 7 (7) | NS |
| Articular involvement | 2 (50) | 44 (46) | NS |
| Raynaud’s phenomenon | 0 (0) | 14 (15) | NS |
| Cutaneous vasculitis | 0 (0) | 13 (14) | NS |
| Pulmonary involvement | 2 (50) | 10 (10) | NS |
| Liver involvement | 2 (50) | 13 (14) | NS |
| Peripheral neuropathy | 0 (0) | 11 (11) | NS |
| Autoimmune thyroiditis | 0 (0) | 16 (17) | NS |
| ANA (+) | 3 (75) | 63 (66) | NS |
| RF (+) | 2 (50) | 42 (44) | NS |
| Ro-SSA (+) | 1 (25) | 25 (26) | NS |
| La-SSB (+) | 0 (0) | 15 (16) | NS |
ANA=antinuclear antibodies. RF= rheumatoid factor. NS=not significant difference.